COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

DRC P&F 2022 Grant Announcement

DRC P&F Grant Announcement


2022 Pilot and Feasibility Projects in Endocrinology & Diabetes

Pilot & Feasibility Program Director: Peter Tontonoz

As part of the mission of our UCSD/UCLA Diabetes Research Center (DRC) grant, the Pilot and Feasibility grant program will support grantees at approximately $40,000-50,000 direct costs (with additional ~55% indirect costs) in 2019. The maximum number of P&F awards an investigator may receive is two. Successful applicants can apply to have their first year of funding renewed for a second year by re-applying the following year, or may submit a second application in a subsequent year.

Applications Period Extended: Friday, April 1st, 2022 to Dr. Peter Tontonoz at ptontonoz@mednet.ucla.edu

The DRC P&F mechanism will fund innovative new projects that will explore the feasibility of novel testable concepts and enhance the endocrine/diabetes research scope within the institutions. A special emphasis on promoting promising junior faculty involved with diabetes research is key to the UCSD/UCLA P&F mission. It is expected that P&F studies will generate preliminary data that will be used by these investigators in diabetes/endocrinology-related R01 applications in the years following their award.
The DRC is also pleased to partner with the CTSIs at UCLA, Cedars and UCSD to specifically support clinical and/or translational research relevant to diabetes. The DRC strongly encourages submission of pilot and feasibility proposals in this area.